Status:
ACTIVE_NOT_RECRUITING
Vasopressin for Septic Shock Pragmatic Trial
Lead Sponsor:
Intermountain Health Care, Inc.
Collaborating Sponsors:
University of Utah
Conditions:
Septic Shock
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Life-threatening low blood pressure due to a serious infection is called "septic shock." Septic shock is treated with vasopressors, medications that raise blood pressure. Sometimes first-line vasopres...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Admitted to a study hospital emergency department (ED) or inpatient care unit
- Administration of vasopressor(s) for septic shock
Exclusion
- None
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
2050 Patients enrolled
Trial Details
Trial ID
NCT06217562
Start Date
February 1 2024
End Date
December 1 2027
Last Update
October 21 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Cassia Regional Hospital
Burley, Idaho, United States, 83318
2
American Fork Hospital
American Fork, Utah, United States, 84003
3
Cedar City Hospital
Cedar City, Utah, United States, 84721
4
Layton Hospital
Layton, Utah, United States, 84041